Myocardial infarction and patent coronary arteries--an uneventful association?

Area of Science:

• Cardiology
• Internal Medicine
• Clinical Research

Background:

• Myocardial infarction (MI) in patients with angiographically patent coronary arteries presents diagnostic and therapeutic challenges.
• Existing research offers conflicting data on the pathophysiology and clinical outcomes of MI with unobstructed coronary arteries.

Purpose of the Study:

• To investigate the clinical course and short-term prognosis of patients experiencing MI despite having patent coronary arteries.
• To compare the clinical outcomes of MI patients with patent coronary arteries against those with significant coronary artery stenoses.

Main Methods:

• A retrospective analysis was conducted on 62 patients with MI and patent coronary arteries.
• A control group of 62 age- and gender-matched patients with MI and significant coronary artery stenoses was included for comparison.
• Data were collected for cardiovascular risk factors and post-infarction complications.

Main Results:

• The study group (patent arteries) showed significantly lower rates of dyslipidemia (29.0% vs 74.2%) and family history of coronary artery disease (25.8% vs 61.3%) compared to the control group (stenotic arteries).
• Post-infarction, the patent artery group experienced fewer ischemic recurrences (40.3% vs 74.2%) and heart failure (17.7% vs 41.9%).
• Rates of mechanical events, arrhythmias, and peripheral thromboembolic complications were similar between the two groups.

Conclusions:

• Smoking was the predominant risk factor identified in patients with MI and patent coronary arteries.
• MI patients with patent coronary arteries demonstrated a better short-term prognosis with reduced risks of ischemic events and heart failure.
• The incidence of mechanical, arrhythmic, and thromboembolic complications did not differ significantly between patients with patent versus stenotic coronary arteries.